Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer
Clinical trial NCT05745415 · COMPLETED
Trial details
- NCT number
- NCT05745415
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-29
- Primary completion
- 2021-03-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.